Figures are presented in US dollars.
Revenue (in thousands)
Foundations: $168,552
US government: $128,180
Other governments, nongovernmental organizations, multilaterals: $45,860
Corporations: $17,233
Investments: $8,198
Individuals/other: $3,265
TOTAL REVENUE $371,288
Expenses (in thousands)
Program-related:
Global Health Programs: $78,317
Product Development: $64,919
Africa: $46,654
Asia, Middle East, and Europe: $35,995
Other: $4,949
Program development: $3,130
Subawards to program partners: $97,163
Subtotal program-related: $331,127
Administrative: $34,377
Fundraising: $1,679
TOTAL EXPENSES: $367,183
Assets (in thousands)
Invested grant funds: $239,814
Cash and cash equivalents: $65,009
Right-of-use assets: $55,359
Contributions and awards receivable: $36,945
Other: $28,222
TOTAL ASSETS: $425,349
Liabilities and net assets (in thousands)
Total liabilities: $367,683
Net assets:
With donor restrictions: $28,899
Without donor restrictions: $28,767
Total net assets: $57,666
TOTAL LIABILITIES AND NET ASSETS: $425,349
The above financial summary is based on PATH’s audited financial statements, which are audited by the firm Clark Nuber P.S. Full copies are available on our finances page.
PATH is an international, nonprofit, nongovernmental organization. Our mission is to advance health equity through innovation and partnerships. Contributions to PATH are tax-exempt under US IRS code 501(c)(3).
2024 PATH annual report
Annual report home | Product development and access | Health and disease management | Health systems strengthening | Financial summary | Leadership | Supporters